Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Organic Letters
|
August 25, 2006
Studies on the synthesis of furanosteroids. I. Viridin models
E Hampton Sessions, Peter A Jacobi
Organic Letters
|
July 28, 2007
Furanosteroid studies. Stereoselective synthesis of the A,B,E-ring core of wortmannin
E Hampton Sessions, Roger T O'Connor, Peter A Jacobi
Organic Letters
|
October 12, 2002
Two-step electrochemical annulation for the assembly of polycyclic systems
Christopher R Whitehead, E Hampton Sessions, Ion Ghiviriga, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 26, 2019
Measurement of Pyridine Nucleotides in Biological Samples Using LC-MS/MS
Chris Petucci, Jeffrey A Culver, Nidhi Kapoor, et al.
Beilstein Journal of Organic Chemistry
|
June 15, 2013
Synthesis and physicochemical characterization of novel phenotypic probes targeting the nuclear factor-kappa B signaling pathway
Paul M Hershberger, Satyamaheshwar Peddibhotla, E Hampton Sessions, et al.
ACS Medicinal Chemistry Letters
|
July 26, 2017
Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors
Bernhard C Lechtenberg, Peter D Mace, E Hampton Sessions, et al.
Nature Communications
|
December 6, 2018
Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme
Zongyang Lv, Lingmin Yuan, James H Atkison, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 19, 2011
Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I)
Sarwat Chowdhury, E Hampton Sessions, Jennifer R Pocas, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 25, 2011
Discovery and optimization of indole and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-II)
E Hampton Sessions, Sarwat Chowdhury, Yan Yin, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 22, 2021
Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition
Mayuko Akiu, Takashi Tsuji, Yoshitaka Sogawa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Organic Letters
|
August 25, 2006
Studies on the synthesis of furanosteroids. I. Viridin models
E Hampton Sessions, Peter A Jacobi
Organic Letters
|
July 28, 2007
Furanosteroid studies. Stereoselective synthesis of the A,B,E-ring core of wortmannin
E Hampton Sessions, Roger T O'Connor, Peter A Jacobi
Organic Letters
|
October 12, 2002
Two-step electrochemical annulation for the assembly of polycyclic systems
Christopher R Whitehead, E Hampton Sessions, Ion Ghiviriga, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 26, 2019
Measurement of Pyridine Nucleotides in Biological Samples Using LC-MS/MS
Chris Petucci, Jeffrey A Culver, Nidhi Kapoor, et al.
Beilstein Journal of Organic Chemistry
|
June 15, 2013
Synthesis and physicochemical characterization of novel phenotypic probes targeting the nuclear factor-kappa B signaling pathway
Paul M Hershberger, Satyamaheshwar Peddibhotla, E Hampton Sessions, et al.
ACS Medicinal Chemistry Letters
|
July 26, 2017
Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors
Bernhard C Lechtenberg, Peter D Mace, E Hampton Sessions, et al.
Nature Communications
|
December 6, 2018
Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme
Zongyang Lv, Lingmin Yuan, James H Atkison, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 19, 2011
Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I)
Sarwat Chowdhury, E Hampton Sessions, Jennifer R Pocas, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 25, 2011
Discovery and optimization of indole and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-II)
E Hampton Sessions, Sarwat Chowdhury, Yan Yin, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 22, 2021
Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition
Mayuko Akiu, Takashi Tsuji, Yoshitaka Sogawa, et al.
Page
of 2